EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 160 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $5,275,000 | -28.6% | 4,586,777 | +55.2% | 0.00% | 0.0% |
| Q4 2021 | $7,390,000 | +3199.1% | 2,955,970 | +6665.3% | 0.00% | – |
| Q3 2021 | $224,000 | -27.5% | 43,693 | +17.3% | 0.00% | – |
| Q2 2021 | $309,000 | -26.6% | 37,250 | -22.9% | 0.00% | – |
| Q1 2021 | $421,000 | -20.4% | 48,330 | -0.6% | 0.00% | – |
| Q4 2020 | $529,000 | -16.6% | 48,626 | -8.6% | 0.00% | – |
| Q3 2020 | $634,000 | -13.0% | 53,178 | +17.0% | 0.00% | – |
| Q2 2020 | $729,000 | -32.8% | 45,449 | -35.0% | 0.00% | – |
| Q1 2020 | $1,085,000 | +14.1% | 69,919 | +80.9% | 0.00% | – |
| Q4 2019 | $951,000 | +95.3% | 38,648 | -18.3% | 0.00% | – |
| Q3 2019 | $487,000 | -64.8% | 47,291 | -57.1% | 0.00% | – |
| Q2 2019 | $1,382,000 | +69.6% | 110,195 | +67.6% | 0.00% | – |
| Q1 2019 | $815,000 | -19.1% | 65,752 | -59.8% | 0.00% | – |
| Q4 2018 | $1,007,000 | +328.5% | 163,414 | +639.8% | 0.00% | – |
| Q3 2018 | $235,000 | -73.6% | 22,090 | -66.3% | 0.00% | – |
| Q2 2018 | $889,000 | -8.5% | 65,569 | +19.8% | 0.00% | – |
| Q1 2018 | $972,000 | +63.4% | 54,714 | +15.5% | 0.00% | – |
| Q4 2017 | $595,000 | -60.1% | 47,352 | -39.4% | 0.00% | – |
| Q3 2017 | $1,490,000 | +21.7% | 78,194 | -3.6% | 0.00% | – |
| Q2 2017 | $1,224,000 | +389.6% | 81,102 | +457.0% | 0.00% | – |
| Q1 2017 | $250,000 | +106.6% | 14,561 | +45.4% | 0.00% | – |
| Q4 2016 | $121,000 | +142.0% | 10,017 | +97.6% | 0.00% | – |
| Q3 2016 | $50,000 | -42.5% | 5,069 | -40.0% | 0.00% | – |
| Q2 2016 | $87,000 | +190.0% | 8,450 | +238.0% | 0.00% | – |
| Q1 2016 | $30,000 | -82.4% | 2,500 | -76.5% | 0.00% | – |
| Q4 2015 | $170,000 | +1207.7% | 10,635 | +1005.5% | 0.00% | – |
| Q3 2015 | $13,000 | -98.1% | 962 | -96.6% | 0.00% | – |
| Q2 2015 | $674,000 | +5516.7% | 28,086 | +4149.0% | 0.00% | – |
| Q1 2015 | $12,000 | -89.2% | 661 | -88.7% | 0.00% | – |
| Q4 2014 | $111,000 | +2.8% | 5,861 | +46.7% | 0.00% | – |
| Q3 2014 | $108,000 | – | 3,994 | +26526.7% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 15 | -99.7% | 0.00% | – |
| Q4 2013 | $93,000 | +1450.0% | 4,468 | +3046.5% | 0.00% | – |
| Q3 2013 | $6,000 | -97.7% | 142 | -98.5% | 0.00% | – |
| Q2 2013 | $263,000 | – | 9,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |